Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBP) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Regen BioPharma (RGBP) over the last 11 years, with Q2 2025 value amounting to $28446.0.

  • Regen BioPharma's Other Working Capital Changes rose 27928.0% to $28446.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$47562.0, marking a year-over-year decrease of 22595.2%. This contributed to the annual value of -$47562.0 for FY2025, which is 22595.2% down from last year.
  • According to the latest figures from Q2 2025, Regen BioPharma's Other Working Capital Changes is $28446.0, which was up 27928.0% from -$50985.0 recorded in Q1 2025.
  • Regen BioPharma's 5-year Other Working Capital Changes high stood at $48174.0 for Q3 2021, and its period low was -$50985.0 during Q1 2025.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$1029.0 (2023), whereas its average is $11.78.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first soared by 40155000.0% in 2021, then tumbled by 16717500.0% in 2022.
  • Quarter analysis of 5 years shows Regen BioPharma's Other Working Capital Changes stood at -$6856.0 in 2021, then plummeted by 72.93% to -$11856.0 in 2022, then surged by 57.83% to -$5000.0 in 2023, then tumbled by 400.46% to -$25023.0 in 2024, then skyrocketed by 213.68% to $28446.0 in 2025.
  • Its last three reported values are $28446.0 in Q2 2025, -$50985.0 for Q1 2025, and -$25023.0 during Q4 2024.